Krebstherapieformen - Molekulare Therapie - Literatur

Literatur

1. Robert C, Thomas L et al: Ipilimumab plus dacarbazine for previoulsy untreated metastatic melanoma. N Engl J Med 2011; 364: 2517–26
2. Zander T, Hallek M: Tyrosinkinaseinhibitoren in der Onkologie. Internist 2011; 52: 595–600
3. Chapman PB, Hauschild A et al for the BRIM-3 Study group Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med 2011; 364: 2507–16